Source link : https://newshealth.biz/health-news/early-treatment-shows-benefit-in-infants-with-presymptomatic-genetic-disease/
(MedPage Today) — Infants up to 6 weeks old with genetically diagnosed presymptomatic spinal muscular atrophy (SMA) treated with oral risdiplam (Evrysdi) appeared to have better functional and survival outcomes compared with a natural history… Source link : https://www.medpagetoday.com/neurology/generalneurology/116978 Author : Publish date : 2025-08-13 21:00:00 Copyright for syndicated content belongs to the linked Source.
The post Early Treatment Shows Benefit in Infants With Presymptomatic Genetic Disease first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-13 21:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8